JPS61207394A - Monomer having nucleotide-like structure and production thereof - Google Patents

Monomer having nucleotide-like structure and production thereof

Info

Publication number
JPS61207394A
JPS61207394A JP4693685A JP4693685A JPS61207394A JP S61207394 A JPS61207394 A JP S61207394A JP 4693685 A JP4693685 A JP 4693685A JP 4693685 A JP4693685 A JP 4693685A JP S61207394 A JPS61207394 A JP S61207394A
Authority
JP
Japan
Prior art keywords
group
adenosine
general formula
isopentenyl
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4693685A
Other languages
Japanese (ja)
Inventor
Tadao Nakaya
忠雄 仲矢
Akio Furukawa
明男 古川
Minoru Imoto
稔 井本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP4693685A priority Critical patent/JPS61207394A/en
Publication of JPS61207394A publication Critical patent/JPS61207394A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Abstract

NEW MATERIAL:A compound shown by the formula I [A is substituent group containing polymerization active group; B is adenosine, 1-(DELTA<2>-isopentenyl) adenosine, inosine uridine, etc.; R<1> and R<2> are alkyl, alkenyl, oxyalkyl, etc.]. USE:A raw material for producing a polymer having improved affinity for organism similar to phospholipid constituting biomembrane. PREPARATION:For example, protected nucleoside shown by the formula BH is reacted with 2-chloro-2-oxo-1,3,2-dioxaphosphorane in the presence of a tertiary amine, and reacted with a tertiary amine (e.g., methacrylic acid 2- dimethylaminoethyl ester, etc.) shown by the formula II, to give the aimed monomer.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、生木構成々分である核酸類似の構造を有する
モノマーおよびその製造方法に関す本発明者らは先に特
徴あるリン脂質類似モノマーの製造方法を提案した〔特
開昭!!−7おり?/号、特願昭jター3り9t、2り
号、特願昭夕?−62り/、?号〕。この方法で得られ
る化合物は、生体内の重要な構成4分であるリン脂質に
類似し、かつ重合活性基を有する為1重合によって生体
親和性の良好なポリマーを与えることが期待出来るもの
であった。
Detailed Description of the Invention [Field of Industrial Application] The present invention relates to a monomer having a structure similar to that of a nucleic acid, which is a component of living wood, and a method for producing the same. Proposed a method for producing monomers [JP-A-Sho! ! -7? / issue, Tokugan Shojter 3 9t, 2nd issue, Tokugan Shoyu? -62ri/,? issue〕. The compound obtained by this method is similar to phospholipids, which are important constituents in living organisms, and has a polymerization active group, so it can be expected that a single polymerization will yield a polymer with good biocompatibility. Ta.

本発明はさらに生港内に広く分布し、細胞の代謝、成長
、増殖などの生体機能に大きな役割を担っているヌクレ
オチドと類似の構造を上記リン脂’301似モノマーに
導入することにより生理活性を有する高分子材料への道
を拓くものである。
The present invention further improves physiological activity by introducing into the phospholipid '301-like monomer a structure similar to nucleotides, which are widely distributed in raw ports and play a major role in biological functions such as cell metabolism, growth, and proliferation. This will pave the way for polymer materials that have the same properties.

〔不発明の目的〕[Aim of non-invention]

不発明は、生体INを構成するリン脂質および生体a能
に重要な役割をもつ核酸に類似の構造をもつ七ツマ−お
よびその製造方法を提供するものである。
An object of the present invention is to provide a hepatoma having a structure similar to that of a phospholipid constituting biological IN and a nucleic acid that plays an important role in biological a function, and a method for producing the same.

〔発明の構成〕[Structure of the invention]

本発明は一般式(1)で表わされるヌクレオシドの1位
に重合活性を有するリン脂質類似基を導入したモノマー
および七の製法に関するものである。
The present invention relates to a monomer in which a phospholipid-like group having polymerization activity is introduced into the 1-position of a nucleoside represented by the general formula (1), and a method for producing No. 7.

RI     Q 〔ここでAは重合活性基を有する置侠基、Bはアデノ、
・′ンb  ’  (d−イソペンテニル)アデノシン
、N’−(△2−イソペンテニル)アデノシン、イノシ
ン、ウリジン、!−ヒドロキシウリジン、!−ヒドロキ
シメチルウリジン、j−ヒドロキシメチルデオキシシチ
ジン、オロチジン。
RI Q [Here, A is a group having a polymerization active group, B is an adeno group,
・'nb' (d-isopentenyl) adenosine, N'-(△2-isopentenyl) adenosine, inosine, uridine,! -Hydroxyuridine! -Hydroxymethyluridine, j-hydroxymethyldeoxycytidine, orotidine.

キサントシン、グアノシン、シチジン、ジヒドロウリジ
ン、チミジン、l−チオウリジン、デオキシアデノシン
、デオキシウリジン、デオキシグアノシン、デオキシシ
チジン、プソイドウリジン、/−メチルアデノシン、j
−メチルウリジン、7−メチルグアノシン、j−メチル
シチジンよりなる群よシ選ばれたヌクレオシドの残基を
表わし、このヌクレオシドは!位で上記一般式(1)の
リン酸基と結合し、かつ、!位取外の水酸基は保護され
ているものであ#)% R1およびR2は各々アルキル
基、アルケニル基、ヒドロキシアルキル基、アルキロイ
ルオキシアルキルI    辞 類似構造と−o−’1s−Bのヌクレオチド類似構造を
e 有するものである。
Xanthosine, guanosine, cytidine, dihydrouridine, thymidine, l-thiouridine, deoxyadenosine, deoxyuridine, deoxyguanosine, deoxycytidine, pseudouridine, /-methyladenosine, j
- Represents the residue of a nucleoside selected from the group consisting of methyluridine, 7-methylguanosine, and j-methylcytidine, and this nucleoside is! It is bonded to the phosphoric acid group of the above general formula (1) at the position, and! The hydroxyl group outside the position is protected. R1 and R2 are each an alkyl group, an alkenyl group, a hydroxyalkyl group, or an alkyloxyalkyl group. It has the structure e.

本発明の一般式(1)のrヒ合物は一般式(II]B 
H(11) 〔ここでB tri 前記一般式+11における定義と
同じ〕在下、2−グIf−−−オキソー/、3.2−ジ
オキサホスホランを反応させ、ついで一般式(II)〔
ここでA、R’、R”は前記一般弐山における定義と同
じ〕で表わされる第三級アミンと反応させることによっ
て容易に製造することが出来る。
The compound of the general formula (1) of the present invention is of the general formula (II]B
In the presence of H(11) [where B tri is the same as the definition in the above general formula +11], 2-gIf--oxo/, 3,2-dioxaphosphorane is reacted, and then general formula (II) [
Here, A, R', and R'' are the same as defined in General Niyama.

本発明の詳細な説明するに、前記一般式(11の化合物
はアデノシンh  ’  (d−イソペンテニル)アデ
ノシン、 N’−(m”−イソペンテニル)アデノシン
、イノシン、ウリジン、!−ヒドロキシウリジン、l 
j−ヒドロキシメチルウリジン。
To explain the present invention in detail, the compound of the general formula (11) is adenosine h'(d-isopentenyl)adenosine, N'-(m''-isopentenyl)adenosine, inosine, uridine, !-hydroxyuridine, l
j-hydroxymethyluridine.

!−ヒドロキシメチルデオキシシチジン、オ四チジン、
キサントシン、グアノシン、シチジン。
! -Hydroxymethyldeoxycytidine, otetratidine,
xanthosine, guanosine, cytidine.

ジヒドロウリジン、・チミジン、l−チオウリジン、デ
オキシアデグシン、デオキシウリジン。
Dihydrouridine, thymidine, l-thiouridine, deoxyadegusine, deoxyuridine.

デオキシグアノシン、デオキシシチジン、プソイドウリ
ジン、l−メチルアデノシン、!−メチルウリジン、ク
ーメチルグアノシン、!−メチルシチジンなる群よυ選
択される。
Deoxyguanosine, deoxycytidine, pseudouridine, l-methyladenosine,! -Methyluridine, Coumethylguanosine,! −Methylcytidine group υ is selected.

所望の!位に、リン脂質類似基を導入して。Desired! By introducing a phospholipid-like group into the position.

一般式(I)で示したモノマーを取得する為に前記一般
式(0)の化合物のr位以外の水酸基は公知の手段によ
って保護される。通常、デオキシヌクレオシドの場合、
ベンジル基、アセチル基、トリチル基などが適当であり
、リボヌクレオシドの場合は、アセチル基、イソプロピ
リデン基、メトキシテトラヒドロピラニル基、テトラヒ
ドロピラニル基、ベンジル基、メトキシエチル誘導体比
などが適当である。
In order to obtain the monomer represented by general formula (I), hydroxyl groups other than the r-position of the compound represented by general formula (0) are protected by known means. Usually, for deoxynucleosides,
Benzyl group, acetyl group, trityl group, etc. are suitable, and in the case of ribonucleosides, acetyl group, isopropylidene group, methoxytetrahydropyranyl group, tetrahydropyranyl group, benzyl group, methoxyethyl derivative ratio, etc. are suitable. .

一コーオキソー/、3.2−ジオキサホスホランと反応
させるが、第三級アミンとしては通常、トリメチルアミ
ン、トリエチルアミンなどのトリアルキルアミンなどが
挙げられる。前記両成分および第3級アミンの使用量は
相互にほぼ等モルで艮い。反応の際に使用される溶媒と
しては。
The reaction is carried out with mono-oxo/3,2-dioxaphosphorane, and the tertiary amine usually includes trialkylamines such as trimethylamine and triethylamine. The amounts of the two components and the tertiary amine used are approximately equimolar to each other. As a solvent used during the reaction.

両成分、第三級アミンおよび反応生成物を溶解しうるも
のが好ましく1例1えば、ジエチルエーテル、テトラヒ
ドロ7ランなどが挙げられる。
Preferably, those that can dissolve both components, the tertiary amine, and the reaction product include diethyl ether, tetrahydro-7rane, and the like.

反応は溶媒中で両成分を混合し、 −SO℃ないしは0
℃で30分ないし数時間反応させれば良く、下記一般式
(V) 〔ここにBは前記一般式(υにおける定義と同じ〕で表
わされる化合物が、はぼ定量的に得られる。
The reaction is carried out by mixing both components in a solvent at -SO°C or 0°C.
The reaction may be carried out at .degree. C. for 30 minutes to several hours, and a compound represented by the following general formula (V) [where B is the same as the definition for the general formula (υ)] can be obtained almost quantitatively.

次に一般式(VJで表わされる化合物は1重合活性基を
含有する第三級アミンと反応させるが。
Next, the compound represented by the general formula (VJ) is reacted with a tertiary amine containing a monomerizable active group.

第三級アミンとしては、下記一般式(Vjは有機基を示
す〕であシ、例えばGとしては次のものが挙げられる。
The tertiary amine has the following general formula (Vj represents an organic group), and examples of G include the following.

−C−o−+CH1+h(ここでhは7〜/コの整数0
          0膵 の整数ヲ示す) 、 −(1−00H,0H−0111
,−(コと−t’ R’はアルキル基またはOH,(O
H,) Co−を表わし、pOH!OR’ はθ〜jの整数をあられす)、0−O−OHO馬−(こ
こでR1+ !−tアルキル基または○Hs(0”z)
 ’O−を表わし、qはθ〜20の整数)。
-C-o-+CH1+h (here h is an integer 0 from 7 to /ko)
0 pancreatic integer) , -(1-00H,0H-0111
, -(co and -t'R' is an alkyl group or OH, (O
H,) represents Co-, pOH! OR' is an integer from θ to j), 0-O-OHO- (where R1+ !-t alkyl group or ○Hs(0"z)
'O-, q is an integer from θ to 20).

OR’ ■ キル基または○H,(OH,) 00− を表わし、r
は/θ 〜/−の整数、θはθ〜−〇の整数を表わす)。
OR' ■ Represents a kill group or ○H, (OH,) 00-, r
represents an integer between /θ and /−, and θ represents an integer between θ and −〇).

○H1OR丁 基またはOH,(OH,看CO−を表わし、tは/〜/
−2の整数、Uはθ〜2Qの整数を表わす)、異なって
いてもよく1例えば、メチル基、エチル基、ヘキシル基
など炭素数/〜30のアルキル基、エチニル基、フロベ
ニル基、フチニル基。
○H1OR represents the group or OH, (OH, kanCO-, t is /~/
-2 integer, U represents an integer from θ to 2Q), which may be different 1 For example, an alkyl group having up to 30 carbon atoms such as methyl group, ethyl group, hexyl group, ethynyl group, flobenyl group, futhynyl group .

等の各種不飽和アルキル基、ア′セトキシメチル基、ア
セトキシエチル基、グロピオニルオキシメチル基、プロ
ピオニルオキシエチル基等のアルキロイルオキシアルキ
ル基であるような化合物が挙げられる。具体的には次の
通りである。
Examples include various unsaturated alkyl groups such as, alkyloxyalkyl groups such as acetoxymethyl group, acetoxyethyl group, glopionyloxymethyl group, and propionyloxyethyl group. Specifically, it is as follows.

OH。Oh.

前記一般式■)で表わされるジオキサホスホラン誘導体
と重合性不飽和基含有第3級アミン誘導体との反応は、
アセトニトリル、N−メチル−2−ピロリドン又はジメ
チルホルムアミド等の溶媒中、Q〜200℃楊度の温度
で数時間〜数十時間両成分を混合することによって行わ
れる。反応生成物である前記一般式(1)で表わされる
リン脂質類似上合物は、適宜の高溶媒に溶解させたのち
これに貧溶媒を加えて析出させるなどの公知の精製法に
よって容易11C1ftMシ得る。
The reaction between the dioxaphosphorane derivative represented by the above general formula (1) and the tertiary amine derivative containing a polymerizable unsaturated group is as follows:
This is carried out by mixing both components in a solvent such as acetonitrile, N-methyl-2-pyrrolidone or dimethylformamide at a temperature of Q to 200° C. for several hours to several tens of hours. The phospholipid-like compound represented by the general formula (1), which is a reaction product, can be easily purified by a 11C1ftM system by a known purification method such as dissolving it in an appropriate high-performance solvent and then adding a poor solvent thereto to precipitate it. obtain.

このようにして得られ九一般式(IIの化合物は。The nine compounds of general formula (II) thus obtained are:

ラジカル重合法により容易に重合することが出来る。得
られた重合物中の水酸基は例えばケタール化反応等によ
って保農されているが、この保護基は例えば少量のトリ
フルオロ酢酸水溶液で処理することによシ脱離すること
が出来、ヌクレオチド類似構造を側鎖に有するポリマー
に転換することが出来る。
It can be easily polymerized by radical polymerization. The hydroxyl groups in the obtained polymer are preserved, for example, by a ketalization reaction, but this protecting group can be removed by treatment with a small amount of trifluoroacetic acid, for example, and a nucleotide-like structure is formed. can be converted into a polymer having this in its side chain.

〔実施例〕〔Example〕

以下実施例により本発明を更に詳細に説明する。 The present invention will be explained in more detail with reference to Examples below.

実施例 r、Of (0,03%k ) ノ2’、3’−〇−イ
ソプロピリデンウリジンを100−のテトラヒドロフラ
ンに溶解し、3.39(0,033モル)のトリエチル
アミンを加えたのち攪拌しながら一2Q℃に冷却する。
Example r, Of (0,03%k) No2',3'-〇-isopropylidene uridine was dissolved in 100-tetrahydrofuran, and 3.39 (0,033 mol) of triethylamine was added thereto, followed by stirring. while cooling to -2Q°C.

この温度でに、7 i (0,OJ Jモル)の2−ク
ロローコーオキソー/、3.2−ジオキサホスホランを
滴下した。滴下終了後Q℃で7時間攪拌をつづけ析出し
たトリエチルアミン場酸塩をグラスフィルターで戸別し
、P液を真空ポンプを用いて譲縮して白色固体を得た。
At this temperature, 7 i (0,0 J moles) of 2-chlorochooxo/3,2-dioxaphosphorane were added dropwise. After the completion of the dropwise addition, stirring was continued for 7 hours at Q°C, and the precipitated triethylamine acid salt was separated using a glass filter, and the P solution was condensed using a vacuum pump to obtain a white solid.

得られた白色固体を50−のジメチルホルムアミドに溶
解し、/ Jr、7 fl (0,72モル)のメタク
リル酸λ−ジメチルアミノエチルエステルを卯え、l1
lrt圧瓶に封入し%20℃で!時間加熱伽盪反応させ
た。反応後、減圧下にジメチルホルムアミドを留去し、
襄縮筏渣に一20m1のジエチルエーテルを加えて数回
洗浄し、真空乾燥すれば//、IIiの次式で表わされ
る目的モノマーが得られた。(u’、3″−〇−イング
ロピリデンウリジンからの収率Z0%)。
The obtained white solid was dissolved in 50-dimethylformamide, 7 fl (0.72 mol) of methacrylic acid λ-dimethylaminoethyl ester was added, and 11
Seal it in an lrt pressure bottle and keep it at %20℃! The mixture was heated and reacted for a period of time. After the reaction, dimethylformamide was distilled off under reduced pressure.
By adding 120 ml of diethyl ether to the slag residue, washing it several times and vacuum drying, the desired monomer IIi was obtained. (Yield Z0% from u', 3″-〇-ingropylidene uridine).

生成モノマーはメタノール、エタノール、アセトン、ク
ロロホルム、ジメチルホルムアミドには可溶であシ、ジ
エチルエーテルには不溶の粘着性のある白色の固体であ
シ、その構造m認は元素分析、工RおよびNMRによシ
おこなったり元素分析(−2水和物として)二〇(計算
値灯、U%、分析値4tj、3/%)1H(計算値6.
56%、分析値6.73%)、N(計算値7.=θ%1
分析値7.16%)。工Rを第1図にNMRを第一図に
示し九。
The monomer produced is a sticky white solid that is soluble in methanol, ethanol, acetone, chloroform, and dimethylformamide but insoluble in diethyl ether, and its structure has been confirmed by elemental analysis, engineering, and NMR. Elemental analysis (as -dihydrate) 20 (calculated value, U%, analytical value 4tj, 3/%) 1H (calculated value 6.
56%, analytical value 6.73%), N (calculated value 7.=θ%1
Analysis value 7.16%). The engineering R is shown in Figure 1, and the NMR is shown in Figure 1.9.

参考PA1/(ポリマーの濫造) 実施伊lで得られたモノマーを少鷲のエタノールに溶解
し1重合開始剤としてアゾビスイソブチロニトリルを加
え、封管中60℃で2時間加部振盪し、重合させた。反
応後内容物を過剰のジエチルエーテル中に投すると白色
のポリマーの析出が見られた。このポリマーを少址のメ
タ7ノール溶解し、過剰のアセトン中に投入する再沈殿
法で精製することによシ、下記の式で表わされるポリマ
ーを得念。(重合収率65%)このポリマーば白色の固
体で、/!θ〜77αに融点をもち、2μθ℃で炭化す
る。メタノール、エタノール、水に可溶、クロロホルム
、ジメチルホルムアミドには離溶であり、アセトン。
Reference PA1/(polymer overproduction) The monomer obtained in Example 1 was dissolved in a small amount of ethanol, azobisisobutyronitrile was added as a polymerization initiator, and the mixture was shaken for 2 hours at 60°C in a sealed tube. , polymerized. After the reaction, the contents were poured into excess diethyl ether, and a white polymer was observed to precipitate. By dissolving this polymer in a small amount of methanol and purifying it by a reprecipitation method by pouring it into excess acetone, a polymer represented by the following formula was obtained. (Polymerization yield 65%) This polymer is a white solid, /! It has a melting point between θ and 77α and carbonizes at 2μθ°C. Soluble in methanol, ethanol, water, soluble in chloroform, dimethylformamide, and acetone.

ニ ジエチルエーテルには不溶である。構造の確認は元素分
析、工R及びNMRでおこなった。元素分析(3水和物
として):C(計算(fuグ3.ソ3%1分所値9t3
.2.2 %〕、H(計算値6.7θ%。
Insoluble in diethyl ether. The structure was confirmed by elemental analysis, engineering R, and NMR. Elemental analysis (as trihydrate): C (calculation (fug3.so3%1 part value 9t3
.. 2.2%], H (calculated value 6.7θ%.

分析1@6.26%)、lJ(計算値6.96%1分析
1鉦6.67%)。工Rを第3図にIv MRをVJ1
図に示しto 参111−2(ポリマーの加水分解) 参;J4;?+/でえられたポリマーてトリフル万口酢
酸の?!%水溶液を少駄加え、室温でg時間放置後真空
ポンプを用いて龜縮したあとアセトンに投入すれば、白
色の沈殿が得られた。(収率!5%) このポリマーは、/60−170℃に融点をもち、26
0℃で炭化する。メタノール、エタノール、水に可溶、
クロロホルム、ジメチルホルムアミドに難溶であシ、ア
セトン、ジエチルエーテルには不溶である。このものの
工Rt−第!図に示した。
analysis 1 @ 6.26%), lJ (calculated value 6.96% 1 analysis 1 = 6.67%). Iv MR in Figure 3
As shown in the figure, Reference 111-2 (hydrolysis of polymers) Reference; J4; Is the polymer obtained from +/ trifluoroacetic acid? ! A small amount of % aqueous solution was added thereto, and the mixture was left at room temperature for g hours, condensed using a vacuum pump, and then poured into acetone to obtain a white precipitate. (Yield! 5%) This polymer has a melting point of /60-170°C and has a melting point of 26
Carbonizes at 0°C. Soluble in methanol, ethanol, water,
Slightly soluble in chloroform and dimethylformamide, insoluble in acetone and diethyl ether. This thing's engineering Rt-No. Shown in the figure.

〔発明の効果〕〔Effect of the invention〕

本発明によれば、マクレオチド類似構造を有する新規な
モノマーが提供される。
According to the present invention, a novel monomer having a macrotide-like structure is provided.

【図面の簡単な説明】[Brief explanation of the drawing]

Claims (4)

【特許請求の範囲】[Claims] (1)一般式( I ) ▲数式、化学式、表等があります▼( I ) 〔ここにAは重合活性基を有する置換基、Bはアデノシ
ン、1−(Δ^2−イソペンテニル)アデノシン、N^
6−(Δ^2−イソペンテニル)アデノシン、イノシン
ウリジン、5−ヒドロキシウリジン、5−ヒドロキシメ
チルウリジン、5−ヒドロキシメチルデオキシシチジン
、オロチジン、キサントシン、グアノシン、シチジン、
ジヒドロウリジン、チミジン、4−チオウリジン、デオ
キシアデノシン、デオキシウリジン、デオキシグアノシ
ン、デオキシシチジン、プソイドウリジン、1−メチル
アデノシン、5−メチルウリジン、7−メチルグアノシ
ン、5−メチルシチジンよりなる群より選ばれたヌクレ
オシドの残基を表わし、このヌクレオシドは5′位で上
記一般式( I )のリン酸基と結合し、かつ、5′位以
外の水酸基は保護されているものであり、R^1および
R^2は各々アルキル基、アルケニル基、ヒドロキシア
ルキル基、アルキロイルオキシアルキル基を示す〕で表
わされるヌクレオチド類似構造をもつモノマー。
(1) General formula (I) ▲Mathematical formulas, chemical formulas, tables, etc.▼(I) [Here, A is a substituent having a polymerization active group, B is adenosine, 1-(Δ^2-isopentenyl)adenosine, N^
6-(Δ^2-isopentenyl)adenosine, inosineuridine, 5-hydroxyuridine, 5-hydroxymethyluridine, 5-hydroxymethyldeoxycytidine, orotidine, xanthosine, guanosine, cytidine,
A nucleoside selected from the group consisting of dihydrouridine, thymidine, 4-thiouridine, deoxyadenosine, deoxyuridine, deoxyguanosine, deoxycytidine, pseudouridine, 1-methyladenosine, 5-methyluridine, 7-methylguanosine, and 5-methylcytidine. This nucleoside is bonded to the phosphoric acid group of the above general formula (I) at the 5' position, and the hydroxyl groups other than the 5' position are protected, and R^1 and R^ 2 represents an alkyl group, an alkenyl group, a hydroxyalkyl group, or an alkyloxyalkyl group, respectively] A monomer having a nucleotide-like structure represented by the following.
(2)一般式( I )において、Aがアクリルオキシエ
チル基、メタクリルオキシエチル基、アクリルアミドエ
チル基、メタクリルアミドエチル基、アクリルオキシプ
ロピル基、メタクリルオキシプロピル基、アクリルアミ
ドプロピル基、メタクリルアミドプロピル基、アリル基
、メタアリル基よりなる群より選ばれた重合活性置換基
であることを特徴とする特許請求の範囲第1項記載のヌ
クレオチド類似構造を有するモノマー。
(2) In general formula (I), A is an acryloxyethyl group, a methacryloxyethyl group, an acrylamideethyl group, a methacrylamideethyl group, an acryloxypropyl group, a methacryloxypropyl group, an acrylamidepropyl group, a methacrylamidepropyl group, 2. The monomer having a nucleotide-like structure according to claim 1, which is a polymerization-active substituent selected from the group consisting of an allyl group and a meta-allyl group.
(3)一般式( I )において、BHが2′,3′−0
−イソプロピリデン基で変換されたアデノシン、1−(
Δ^2−イソペンテニル)アデノシン、N^6−(Δ^
2−イソペンテニル)アデノシン、ウリジン、オロチジ
ン、キサントシン、グアノシン、シチジン、ジヒドロウ
リジン、4−チオウリジン、プソイドウリジン、1−メ
チルアデノシン、5−メチルウリジン、5−メチルシチ
ジンより成る群より選ばれた保護ヌクレオシドであるこ
とを特徴とする特許請求の範囲第1項または第2項記載
のヌクレオチド類似構造を有するモノマー。
(3) In general formula (I), BH is 2',3'-0
-adenosine converted with isopropylidene group, 1-(
Δ^2-isopentenyl) adenosine, N^6-(Δ^
a protected nucleoside selected from the group consisting of (2-isopentenyl) adenosine, uridine, orotidine, xanthosine, guanosine, cytidine, dihydrouridine, 4-thiouridine, pseudouridine, 1-methyladenosine, 5-methyluridine, 5-methylcytidine; A monomer having a nucleotide-like structure according to claim 1 or 2, characterized in that:
(4)一般式(II) ▲数式、化学式、表等があります▼(II) 〔ここにBは、アデノシン、1−(Δ^2−イソペンテ
ニル)アデノシン、N^6−(Δ^2−イソペンテニル
)アデノシン、イノシン、ウリジン、5−ヒドロキシウ
リジン、5−ヒドロキシメチルウリジン、5−ヒドロキ
シメチルデオキシシチジン、オロチジン、キサントシン
、グアノシン、シチジン、ジヒドロウリジン、チミジン
、4−チオウリジン、デオキシアデノシン、デオキシウ
リジン、デオキシグアノシン、デオキシシチジン、プソ
イドウリジン、1−メチルアデノシン、5−メチルウリ
ジン、7−メチルグアノシン、5−メチルシチジン、よ
りなる群より選ばれたヌクレオシドの残基を示す〕で表
わされる保護ヌクレオシドを第3級アミンの存在下、2
−クロロ−2−オキソ−1,3,2−ジオキサホスホラ
ンと反応させついで一般式(III) ▲数式、化学式、表等があります▼(III) 〔ここでAは重合活性基を有する置換基、R^1および
R^2は各々アルキル基、アルケニル基、ヒドロキシア
ルキル基、アルキロイルオキシアルキル基を示す〕で表
わされる第三級アミンと反応させることを特徴とする一
般式( I )で表わされるヌクレオチド類似構造をもつ
モノマーの製法。 ▲数式、化学式、表等があります▼( I ) 〔上記式中、A、B、R^1およびR^2は前記と同一
意義を示す〕
(4) General formula (II) ▲Mathematical formulas, chemical formulas, tables, etc.▼(II) [Here B is adenosine, 1-(Δ^2-isopentenyl)adenosine, N^6-(Δ^2- isopentenyl) adenosine, inosine, uridine, 5-hydroxyuridine, 5-hydroxymethyluridine, 5-hydroxymethyldeoxycytidine, orotidine, xanthosine, guanosine, cytidine, dihydrouridine, thymidine, 4-thiouridine, deoxyadenosine, deoxyuridine, Deoxyguanosine, deoxycytidine, pseudouridine, 1-methyladenosine, 5-methyluridine, 7-methylguanosine, 5-methylcytidine. In the presence of grade amine, 2
-By reacting with chloro-2-oxo-1,3,2-dioxaphosphorane, the general formula (III) ▲There are numerical formulas, chemical formulas, tables, etc.▼(III) [Here, A is a substitution having a polymerization active group. group, R^1 and R^2 each represent an alkyl group, an alkenyl group, a hydroxyalkyl group, or an alkyloxyalkyl group. A method for producing a monomer having a nucleotide-like structure as shown. ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) [In the above formula, A, B, R^1 and R^2 have the same meaning as above]
JP4693685A 1985-03-09 1985-03-09 Monomer having nucleotide-like structure and production thereof Pending JPS61207394A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4693685A JPS61207394A (en) 1985-03-09 1985-03-09 Monomer having nucleotide-like structure and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4693685A JPS61207394A (en) 1985-03-09 1985-03-09 Monomer having nucleotide-like structure and production thereof

Publications (1)

Publication Number Publication Date
JPS61207394A true JPS61207394A (en) 1986-09-13

Family

ID=12761201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4693685A Pending JPS61207394A (en) 1985-03-09 1985-03-09 Monomer having nucleotide-like structure and production thereof

Country Status (1)

Country Link
JP (1) JPS61207394A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130053470A1 (en) * 2011-06-24 2013-02-28 Fanny Raisin-Dadre Biocompatible, biomimetic ampholyte materials

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130053470A1 (en) * 2011-06-24 2013-02-28 Fanny Raisin-Dadre Biocompatible, biomimetic ampholyte materials
CN103917548A (en) * 2011-06-24 2014-07-09 生物相互作用有限公司 Biocompatible, biomimetic ampholyte materials
US9567357B2 (en) * 2011-06-24 2017-02-14 Biointeractions Ltd. Biocompatible, biomimetic ampholyte materials

Similar Documents

Publication Publication Date Title
Lin et al. Synthesis and antiviral activity of various 3'-azido analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV)
Martin et al. Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)
US5216141A (en) Oligonucleotide analogs containing sulfur linkages
CN102282155B (en) The synthetic method of the nucleic acid of phosphorus atoms modification
US4424211A (en) 2&#39;Deoxy-5-(2-halogenovinyl)-uridines, pharmaceutical compositions and method of use
JP2021500311A (en) Techniques for oligonucleotide preparation
CN113748116A (en) Techniques useful for oligonucleotide preparation
CA2119351C (en) Phosphoramidate analogs of 5-fluoro-2&#39;-deoxyuridine
NO179675B (en) Pyrimidine nucleoside derivatives and pharmaceutical compositions containing them
US20030130213A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof
JPS61257926A (en) Therapeutical nucleoside
Gildea et al. The synthesis of 2-pyrimidinone nucleosides and their incorporation into oligodeoxynucleotides
WO1992003462A1 (en) New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs
WO2005014609A2 (en) Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue
Rios Morales et al. Diastereoselective Synthesis of cycloSaligenyl‐Nucleosyl‐Phosphotriesters
JPS637199B2 (en)
KR20030032924A (en) Process for the preparation of phosphorothioate triesters
JPS61207394A (en) Monomer having nucleotide-like structure and production thereof
JPS59502025A (en) Method for producing oligonucleoside phosphonates
Fernández et al. Synthesis of 2′, 3′-dideoxy-3′, 3′-difluoro and 2′, 3′-dideoxy-2′, 2′-difluoro-pyranosyl nucleosides analogues of gemcitabine
EP0331080A2 (en) Imidazole derivatives, process for production thereof, and use thereof
KR20050109939A (en) Nucleotide lipid ester derivatives
US6444798B1 (en) Chimeras of sulfur-linked oligonucleotide analogs and DNA and RNA
ITMI951715A1 (en) METHOD FOR THE PREPARATION OF 1-B-D-ARABINOFURANOSILCITOSINA
CA1295269C (en) Polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon